307 related articles for article (PubMed ID: 31755015)
1. Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists.
Sanyal C; Husereau D
Appl Health Econ Health Policy; 2020 Jun; 18(3):375-392. PubMed ID: 31755015
[TBL] [Abstract][Full Text] [Related]
2. Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses.
Sanyal C; Husereau DR
Value Health; 2019 Dec; 22(12):1450-1457. PubMed ID: 31806202
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review.
Dawoud DM; Haines A; Wonderling D; Ashe J; Hill J; Varia M; Dyer P; Bion J
Pharmacoeconomics; 2019 Oct; 37(10):1241-1260. PubMed ID: 31179514
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review.
Zhu J; Zhou Y; Wang G
Diabetes Ther; 2024 Jan; 15(1):61-76. PubMed ID: 37957464
[TBL] [Abstract][Full Text] [Related]
5. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis.
Freeman K; Mistry H; Tsertsvadze A; Royle P; McCarthy N; Taylor-Phillips S; Manuel R; Mason J
Health Technol Assess; 2017 Apr; 21(23):1-188. PubMed ID: 28619124
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of economic evaluations of pharmacist services.
Price E; Shirtcliffe A; Fisher T; Chadwick M; Marra CA
Int J Pharm Pract; 2023 Sep; 31(5):459-471. PubMed ID: 37543960
[TBL] [Abstract][Full Text] [Related]
7. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
[TBL] [Abstract][Full Text] [Related]
8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?
Aguiar PM; Lima TM; Storpirtis S
J Clin Pharm Ther; 2016 Apr; 41(2):189-97. PubMed ID: 27009796
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Miroshnychenko A; Uhlman K; Malone J; Waltho D; Thoma A
J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2458-2466. PubMed ID: 34217645
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
12. Economic Evaluation of Hospital and Community Pharmacy Services.
Gammie T; Vogler S; Babar ZU
Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
[TBL] [Abstract][Full Text] [Related]
13. Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of economic evaluations of preoperative smoking cessation for preventing surgical complications.
McCaffrey N; Higgins J; Greenhalgh E; White SL; Graves N; Myles PS; Cunningham JE; Dean E; Doncovio S; Briggs L; Lal A
Int J Surg; 2022 Aug; 104():106742. PubMed ID: 35764251
[TBL] [Abstract][Full Text] [Related]
15. The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations.
Yang F; Liao M; Wang P; Yang Z; Liu Y
Appl Health Econ Health Policy; 2021 Mar; 19(2):163-180. PubMed ID: 33047212
[TBL] [Abstract][Full Text] [Related]
16. Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations.
Gavan S; Bruce I; Payne K
Lupus Sci Med; 2020 Jul; 7(1):. PubMed ID: 32723809
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia.
Wang L; Shi F; Guan X; Xu H; Liu J; Li H
Front Public Health; 2021; 9():689123. PubMed ID: 34746073
[No Abstract] [Full Text] [Related]
18. Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs.
Ghabri S; Lam L; Bocquet F; Spath HM
Pharmacoeconomics; 2020 May; 38(5):459-471. PubMed ID: 32052376
[TBL] [Abstract][Full Text] [Related]
19. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluations of clinical pharmacy services: 2006-2010.
Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
